UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union

The NHS will be forced to divert around £45bn from essential services under a UK-US pharmaceuticals deal, increasing potentially preventable deaths by 229,000, analysis from a doctors' union has found.